These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones. Evans R, Nesbit M, Askin F, Burgert O, Cangir A, Foulkes M, Gehan E, Gilula L, Kissane J, Makley J. Int J Radiat Oncol Biol Phys; 1985 Jan 15; 11(1):129-36. PubMed ID: 3881374 [Abstract] [Full Text] [Related]
7. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial. Andreou D, Ranft A, Gosheger G, Timmermann B, Ladenstein R, Hartmann W, Bauer S, Baumhoer D, van den Berg H, Dijkstra PDS, Dürr HR, Gelderblom H, Hardes J, Hjorth L, Kreyer J, Kruseova J, Leithner A, Scobioala S, Streitbürger A, Tunn PU, Wardelmann E, Windhager R, Jürgens H, Dirksen U, GPOH-Euro-EWING99 consortium. Clin Orthop Relat Res; 2020 Feb 15; 478(2):290-302. PubMed ID: 31580267 [Abstract] [Full Text] [Related]
8. [Therapy of non-metastatic Ewing's sarcoma (pelvis excluded). Results obtained in 48 cases combining local therapy (radiation and/or surgical) and adjuvant chemotherapy with vincristine, adriamycin, dactinomycin and cyclophosphamide]. Sudanese A, Avella M, Toni A, Boriani S, Baldini N, Monesi M, Battistini A, Mancini A, Campanacci M. Minerva Med; 1987 Apr 15; 78(7):473-82. PubMed ID: 3574734 [Abstract] [Full Text] [Related]
13. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies. Bacci G, Picci P, Ruggieri P, Ferrari S, Mercuri M, Fabbri N, Rosito P, Barbieri E, Ferraro A, Casadei R. J Chemother; 1993 Aug 15; 5(4):247-57. PubMed ID: 8229153 [Abstract] [Full Text] [Related]
14. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. Nesbit ME, Gehan EA, Burgert EO, Vietti TJ, Cangir A, Tefft M, Evans R, Thomas P, Askin FB, Kissane JM. J Clin Oncol; 1990 Oct 15; 8(10):1664-74. PubMed ID: 2213103 [Abstract] [Full Text] [Related]
16. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study. Evans RG, Nesbit ME, Gehan EA, Garnsey LA, Burgert O, Vietti TJ, Cangir A, Tefft M, Thomas P, Askin FB. J Clin Oncol; 1991 Jul 15; 9(7):1173-80. PubMed ID: 2045857 [Abstract] [Full Text] [Related]
19. Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli. Bacci G, Ferrari S, Bertoni F, Donati D, Bacchini P, Longhi A, Brach Del Prever A, Forni C, Rimondini S. J Clin Oncol; 2000 Feb 15; 18(4):885-92. PubMed ID: 10673532 [Abstract] [Full Text] [Related]